News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Groundbreaking Drug Development Technology: Frost & Sullivan Award Goes to Imperacer


10/30/2008 9:11:30 AM

DORTMUND, Germany--(BUSINESS WIRE)--The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec, a bioanalytical company based in Dortmund, Germany. Chimera Biotec is recognized for its pioneering ImperacerĀ® ultra-sensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzyme-linked Immunosorbent Assay). With a unique value proposition in the drug development and diagnostic markets, Chimera's innovative ImperacerĀ® products and services have experience widespread market acceptance.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES